Neursantys
PrivateLast Round
Grant
Jul 27, 2024
Est. Valuation
$3.12M
Total Funding Raised
$842,500
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neursantys operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Grant round in July 2024.
Neursantys is a medical devices company developing non-invasive bioelectronic devices and treatments to address neuromotor conditions caused by aging, trauma, or disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neursantys Comparables
Compare Neursantys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RxFunction | 80% | |
| Bioventus | 78% | |
| GaitBetter | 74% |
For institutional investors. Book with your work email.
Neursantys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 27, 2024 | ||||
| Grant | Jun 12, 2024 | ||||
| Accelerator | Oct 1, 2023 | ||||
| Grant | Apr 28, 2023 | ||||
| Seed | Mar 14, 2023 | ||||
Grant | Jun 30, 2022 |
For institutional investors. Book with your work email.
Neursantys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| a2 Collective | Grant |
| AgeTech Collaborative | Grant |
| mHUB Ventures | Seed, Accelerator |
| National Institute on Aging | Grant |
| National Institute on Aging | Grant |
| Canadian Space Agency | Grant |
| Edward-Elmhurst Health Venture Capital | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 36% MoM.
- Jun 18, 2026
Monthly visitors grew 611% MoM, reaching 1K.
For institutional investors. Book with your work email.
Neursantys Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neursantys's valuation, stock price, and market status.
Is Neursantys a public or private company?
Neursantys is a private company.
What is the current stock price of Neursantys?
Neursantys is a private company, so its shares have no public market price. Caplight tracks Neursantys's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neursantys worth (valuation)?
Neursantys's valuation is estimated at $3.1M based on funding round data.
Can I buy Neursantys stock?
Neursantys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neursantys's last funding round?
Neursantys's most recent funding round was Grant on July 27, 2024.
Who are the main investors in Neursantys?
Key investors in Neursantys include mHUB Ventures.
Will Neursantys IPO soon?
No public IPO plans have been announced for Neursantys.
How can I track Neursantys secondary market activity?
Caplight tracks bids, offers, and trades in Neursantys's shares on secondary markets.